series-c-plus
Stage
1
Investors
About
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel small-molecule immuno-oncology therapies, including selective ITK inhibitors, to treat cancer and immune diseases.
Explore Corvus Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.